Literature DB >> 31292754

Healthcare provider utility ratings of a psychosocial screening summary: from diagnosis to 6 months.

Leandra Desjardins1, Laurel Etkin-Spigelman2, Kelly Hancock2, Joanna Chung3, Wendy Shama2, Denise Mills2, Sarah Alexander2, Maru Barrera2.   

Abstract

BACKGROUND: Psychosocial screening has been proposed as a core standard of care in pediatric oncology. However, there has been limited application of this standard thus far. Understanding healthcare provider (HCP) attitudes towards psychosocial screening is an important element towards furthering implementation initiatives of standard screening practices in pediatric oncology.
OBJECTIVE: To compare HCP perceptions of the utility of a psychosocial risk summary by discipline (oncologist, nurse, social worker), risk level (Universal, Targeted, Clinical) derived from the Psychosocial Assessment Tool (PAT), and time (shortly after a child's diagnosis [T1] and 6 months later [T2]).
METHOD: All participating HCPs (oncologists, nurses, social workers) were asked to rate how useful they found the psychosocial risk summary using a visual analogue scale (VAS).
RESULTS: The psychosocial risk summary was perceived as equally useful across providers (oncologists, nurses, social workers) and PAT risk levels at T1. At T2, the psychosocial risk summary was perceived as more useful by oncologists and nurses than social workers, and summaries indicating elevated risk were perceived as more useful than those indicating low risk. Overall, healthcare providers reported greater utility of psychosocial risk summary near diagnosis compared with 6 months later, largely driven by lower utility ratings reported by social workers at T2.
CONCLUSION: Understanding perceived utility and factors affecting perceived utility is a key component to designing effective implementation strategies for systematic psychosocial screening. Active engagement of HCPs in the screening process is critical in improving implementation of psychosocial screening throughout pediatric cancer treatment.

Entities:  

Keywords:  Distress screening; Pediatric oncology; Psychosocial

Mesh:

Year:  2019        PMID: 31292754     DOI: 10.1007/s00520-019-04969-w

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  24 in total

1.  Feasibility of clinical psychosocial screening in pediatric oncology: Implementing the PAT2.0.

Authors:  Maria C McCarthy; Claire E Wakefield; Sharon DeGraves; Madeleine Bowden; Deborah Eyles; Lauren K Williams
Journal:  J Psychosoc Oncol       Date:  2016-07-11

2.  Standards for the Psychosocial Care of Children With Cancer and Their Families: An Introduction to the Special Issue.

Authors:  Lori Wiener; Anne E Kazak; Robert B Noll; Andrea Farkas Patenaude; Mary Jo Kupst
Journal:  Pediatr Blood Cancer       Date:  2015-09-23       Impact factor: 3.167

3.  Psychosocial standards of care for children with cancer and their families: A national survey of pediatric oncology social workers.

Authors:  Barbara Jones; Jennifer Currin-Mcculloch; Wendy Pelletier; Vicki Sardi-Brown; Peter Brown; Lori Wiener
Journal:  Soc Work Health Care       Date:  2018-04

4.  Assessment of family psychosocial functioning in survivors of pediatric cancer using the PAT2.0.

Authors:  Jordan Gilleland; Bonney Reed-Knight; Sarah Brand; Anya Griffin; Karen Wasilewski-Masker; Lillian Meacham; Ann Mertens
Journal:  Psychooncology       Date:  2013-03-26       Impact factor: 3.894

5.  Identifying psychosocial risk indicative of subsequent resource use in families of newly diagnosed pediatric oncology patients.

Authors:  Anne E Kazak; M Catherine Cant; Merritt M Jensen; Mary McSherry; Mary T Rourke; Wei-Ting Hwang; Melissa A Alderfer; David Beele; Steven Simms; Beverly J Lange
Journal:  J Clin Oncol       Date:  2003-09-01       Impact factor: 44.544

6.  External validity and reliability of the Psychosocial Assessment Tool (PAT) among Canadian parents of children newly diagnosed with cancer.

Authors:  M Barrera; K Hancock; A Rokeach; D Cataudella; E Atenafu; D Johnston; A Punnett; P C Nathan; U Bartels; M Silva; M Cassidy; P Jansen; W Shama; C Greenberg
Journal:  Pediatr Blood Cancer       Date:  2013-09-17       Impact factor: 3.167

7.  Family psychosocial risk, distress, and service utilization in pediatric cancer: predictive validity of the Psychosocial Assessment Tool.

Authors:  Melissa A Alderfer; Ifigenia Mougianis; Lamia P Barakat; David Beele; Susan DiTaranto; Wei-Ting Hwang; Anne T Reilly; Anne E Kazak
Journal:  Cancer       Date:  2009-09-15       Impact factor: 6.860

8.  Healthcare Professionals' Knowledge of Family Psychosocial Problems in Pediatric Cancer: A Pilot Study.

Authors:  Maru Barrera; Alan Rokeach; Priyanga Yogalingam; Kelly Hancock; Donna L Johnston; Danielle Cataudella; Marilyn Cassidy; Angela S Punnett; Wendy Shama
Journal:  Cancer Nurs       Date:  2016 Jul-Aug       Impact factor: 2.592

9.  Perceived benefits of and barriers to psychosocial risk screening in pediatric oncology by health care providers.

Authors:  Maru Barrera; Sarah Alexander; Wendy Shama; Denise Mills; Leandra Desjardins; Kelly Hancock
Journal:  Pediatr Blood Cancer       Date:  2018-08-29       Impact factor: 3.167

10.  First experience with electronic feedback of the Psychosocial Assessment Tool in pediatric cancer care.

Authors:  Sasja A Schepers; Simone M Sint Nicolaas; Heleen Maurice-Stam; Elisabeth M van Dijk-Lokkart; Esther M M van den Bergh; Nienke de Boer; Chris M Verhaak; Martha A Grootenhuis
Journal:  Support Care Cancer       Date:  2017-05-11       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.